| Session 3
Chairpersons主持：
RUAN Changgeng 阮长耿 LI Xiaoying 李小鹰
08:00-08:50
Prevention and Treatment Strategy of Latrogenic
Thrombosis
内科系统病人静脉血栓的预防和治疗策略
LI Xiaoying 李小鹰
08:50-09:40
Advancement of Antiplatelet Agents
抗血小板药物进展
RUAN Changgeng阮长耿
09:40-10:10
Break & Exhibition 休息与观展
10:10-11:00
Which is Better--- Thrombolylitic Therapy or
PCI in
Patients with AMI?
AMI溶栓治疗/介入治疗如何选择？
MA Changsheng 马长生
11:00-11:50
Pay More Atlention: Thrombocytopenia Induced
by
Heparin
警惕肝素诱导的血小板减少症
SHI Xubo 史旭波
11:50-12:00
Panel Discussion 讨论 |
Session 4
Chairpersons主持：
LI Jiazeng李家增 HAN Yaling韩雅玲
13:00-13:45
Antiplatelet Agents and Cardiovascular Disease
抗血小板药物在冠心病患者中的应用
HAN Yaling 韩雅玲
13:45-14:30
Evaluation of GPIIb/IIIa Receptor Blockers
GPⅡb/Ⅲa受体拮抗剂出路何在？
YAN Xiaowei 严晓伟
14:30-15:15
Break & Exhibition 休息与观展
15:15-15:30
Evaluation of Direct Thrombin Inhibitors Beyond
HIT
除了HIT，直接凝血酶抑制剂还有价值吗？
XU Juntang 许俊堂
16:30-16:15
Questions and Answers to Theory and Clinicalproblems
on Thrombus
血栓基础与临床热点问答
LI Jiazeng 李家增
16:15-16:30
Panel Discussion讨论 |
